takisbiotech
Menu
Close
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company
About Us
Our Team
Careers
Our Services
Vaccines & Preclinical Immunology
Predictive Models
Monoclonal Antibodies
Recombinant Proteins
Facilities
BSL-3
GMP
Research
Funded Projects
Internal Research
Papers
Congresses
News
Contact Us
Company news
Stay updated with Takis latest news!
CEO, Luigi Aurisicchio, recently joined the event Italy and Latin America
May 9, 2024
|
News
|
authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility
May 6, 2024
|
News
|
CEO Luigi Aurisicchio attended the 4th Consortium Meeting of the MIRIA EU Project in Prague
May 2, 2024
|
News
|
Workshop on Autologous DNA-Based Antibody Production
April 26, 2024
|
News
|
Building a ballon tower was more challenging than expected… but it was a great experience to fine-tune our goal-setting skills!
April 5, 2024
|
News
|
We are thrilled to announce a new initiative promoted by Takis and Vitares and involving Largo Brodolini High School in Pomezia
March 25, 2024
|
News
|
Conference hosted by Sapienza Università di Roma as part of the mid-term date of the Roma Technopole project
March 19, 2024
|
News
|
Emanuele Marra, our COO, has been elected to the board of directors of the pharmaceutical and biomedical section of Unindustria
March 7, 2024
|
News
|
The book “Il Destino in una Parola”, written by our own Erika Salvatori and Emanuele Marra, in collaboration with Labozeta SpA
February 22, 2024
|
News
|
1
2
3
4
